Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

Cited in:

CrossRef

This article has been cited by:

1. 1
   Daniele Santini, Vladimir Virzi, Enrico Vasile, Bruno Vincenzi, Vincenzo Catalano, Francesco Graziano, Gianluca Masi, Giuseppe Bronte, Antonio Russo, Alfredo Falcone, Giuseppe Tonini, A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients, Oncology, 2012, 82, 2, 75

   CrossRef

2. 2
   Soo-Fan Ang, Sze-Huey Tan, Han-Chong Toh, Donald Y.H. Poon, Simon Y.K. Ong, Kian-Fong Foo, Su-Pin Choo, Activity of Thalidomide and Capecitabine in Patients With Advanced Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2012, 35, 3, 222

   CrossRef

3. 3
   Masaru Konishi, Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction, Journal of Hepato-Biliary-Pancreatic Sciences, 2012,

   CrossRef

4. 4
   Adriana Romiti, Chiara D’Antonio, Angelo Zullo, Ida Sarcina, Roberta Rocco, Viola Barucca, Valeria Durante, Paolo Marchetti, Chemotherapy for the Biliary Tract Cancers: Moving Toward Improved Survival Time, Journal of Gastrointestinal Cancer, 2012,

   CrossRef

5. 5
   Ghassan K. Abou-Alfa, Leonard B. Saltz, Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 2012,

   CrossRef

6. 6
   Sidi Mohammed Bouchentouf, Soundouss Raissouni, Ibrahima Sall, Hakim El Kaoui, Hicham Baba, Ahmed Bounaim, Abdelmounim Ait Ali, Khalid Sair, Aziz Zentar, Incidental gallbladder cancer: what management?, Oncology Reviews, 2011, 5, 4, 241

   CrossRef

7. 7
   Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Akira Nakashima, Naru Kondo, Ryutaro Sakabe, Hironori Kobayashi, Taijiro Sueda, Is Para-aortic Lymph Node Metastasis a Contraindication for Radical Resection in Biliary Carcinoma?, World Journal of Surgery, 2011, 35, 5, 1085

   CrossRef

8. 8
   Weijing Sun, Davendra Sohal, Daniel G. Haller, Kristine Mykulowycz, Mark Rosen, Michael C. Soulen, Millie Caparro, Ursina R. Teitelbaum, Bruce Giantonio, Peter J. O'Dwyer, Abraham Shaked, Rajender Reddy, Kim Olthoff, Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma, Cancer, 2011, 117, 14

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(169K)
   • References
9. 9
   Stephen H. Wrzesinski, Tamar H. Taddei, Mario Strazzabosco, Systemic Therapy in Hepatocellular Carcinoma, Clinics in Liver Disease, 2011, 15, 2, 423

   CrossRef

10. 10
    Clarinda W. L. Chua, Su Pin Choo, Targeted Therapy in Hepatocellular Carcinoma, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

11. 11
    Yong Xia, Yinghe Qiu, Jun Li, Lehua Shi, Kui Wang, Tao Xi, Feng Shen, Zhenlin Yan, Mengchao Wu, Adjuvant Therapy With Capecitabine Postpones Recurrence of Hepatocellular Carcinoma After Curative Resection: A Randomized Controlled Trial, Annals of Surgical Oncology, 2010, 17, 12, 3137

    CrossRef

12. 12
    Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin, Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010, 4, 2, 439

    CrossRef

13. 13
    Manal M. Abdel Wahab, Lobna R. Ezz Elarab, Mohamed A. Ezz Elarab, Capecitabine plus cisplatin treatment in patients with advanced hepatocellular carcinoma, The Chinese-German Journal of Clinical Oncology, 2010, 9, 12, 718

    CrossRef

14. You have free access to this content14
    Chapter 4: Chemotherapy and radiotherapy, Hepatology Research, 2010, 40,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(147K)
    • References
15. 15
    Domenico Alvaro, Renato Cannizzaro, Roberto Labianca, Francesca Valvo, Fabio Farinati, Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO), Digestive and Liver Disease, 2010, 42, 12, 831

    CrossRef

16. 16
    Jens Kruth, Johanna Nissen, Thomas Ernst, Melanie Kripp, Nadine Lukan, Kirsten Merx, Wolf-Karsten Hofmann, Andreas Hochhaus, Ralf-Dieter Hofheinz, Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma, Journal of Cancer Research and Clinical Oncology, 2010, 136, 12, 1845

    CrossRef

17. 17
    C-H Hsu, T-S Yang, C Hsu, H C Toh, R J Epstein, L-T Hsiao, P-J Chen, Z-Z Lin, T-Y Chao, A-L Cheng, Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma, British Journal of Cancer, 2010, 102, 6, 981

    CrossRef

18. 18
    Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber, Hepatocellular Carcinoma: Current Management, Current Problems in Surgery, 2010, 47, 1, 10

    CrossRef

19. 19
    Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Akira Nakashima, Naru Kondo, Ryutaro Sakabe, Hiroki Ohge, Taijiro Sueda, Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma, Annals of Surgical Oncology, 2010, 18, 3, 651

    CrossRef

20. 20
    Woo Seok Kim, Dong Wook Choi, Dong Do You, Chuan Yu Ho, Jin Seok Heo, Seong Ho Choi, Risk Factors Influencing Recurrence, Patterns of Recurrence, and the Efficacy of Adjuvant Therapy After Radical Resection for Gallbladder Carcinoma, Journal of Gastrointestinal Surgery, 2010, 14, 4, 679

    CrossRef

21. 21
    Neil Kopek, Marianne Ingerslev Holt, Anders Traberg Hansen, Morten Høyer, Stereotactic body radiotherapy for unresectable cholangiocarcinoma, Radiotherapy and Oncology, 2010, 94, 1, 47

    CrossRef

22. 22
    Stefano Cereda, Paolo Passoni, Michele Reni, Maria G. Viganò, Luca Aldrighetti, Roberto Nicoletti, Eugenio Villa, The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma, Cancer, 2010, 116, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(135K)
    • References
23. 23
    S. Pesque, T. Baere, V. Boige, Traitements du carcinome hépatocellulaire non accessible à un traitement curatif: actualités, Oncologie, 2010, 12, 10, 615

    CrossRef

24. 24
    Stefania Mosconi, Giordano D. Beretta, Roberto Labianca, Maria G. Zampino, Gemma Gatta, Volker Heinemann, Cholangiocarcinoma, Critical Reviews in Oncology/Hematology, 2009, 69, 3, 259

    CrossRef

25. 25
    J. O. Lee, K. W. Lee, D. Y. Oh, J. H. Kim, S. A. Im, T. Y. Kim, Y. J. Bang, Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma, Annals of Oncology, 2009, 20, 8, 1402

    CrossRef

26. 26
    Cherif Boutros, Ponnandai Somasundar, N. Joseph Espat, Extrahepatic Cholangiocarcinoma: Current Surgical Strategy, Surgical Oncology Clinics of North America, 2009, 18, 2, 269

    CrossRef

27. You have free access to this content27
    Inkeun Park, Jae-Lyun Lee, Min-Hee Ryu, Tae-Won Kim, Sung Sook Lee, Do Hyun Park, Sang Soo Lee, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy, Cancer, 2009, 115, 18

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(164K)
    • References
28. 28
    Amit Singal, Theodore H Welling, Jorge A Marrero, Role of liver transplantation in the treatment of cholangiocarcinoma, Expert Review of Anticancer Therapy, 2009, 9, 4, 491

    CrossRef

29. 29
    Allen L. Cohn, J. William Myers, Steven Mamus, Charles Deur, Steven Nicol, Karen Hood, Muhammad M. Khan, Des Ilegbodu, Lina Asmar, A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma, Investigational New Drugs, 2008, 26, 4, 381

    CrossRef

30. 30
    Jonathan Hernandez, Sarah M. Cowgill, Sam Al-Saadi, Desiree Villadolid, Sharona Ross, Emily Kraemer, Mark Shapiro, John Mullinax, Jennifer Cooper, Steven Goldin, Emmanuel Zervos, Alexander Rosemurgy, An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection, Annals of Surgical Oncology, 2008, 15, 3, 807

    CrossRef

31. 31
    O Nehls, H Oettle, J T Hartmann, R-D Hofheinz, H G Hass, M S Horger, U Koppenhöfer, A Hochhaus, J Stieler, J Trojan, M Gregor, B Klump, Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial, British Journal of Cancer, 2008, 98, 2, 309

    CrossRef

32. 32
    C. Dreyer, C. Le Tourneau, S. Faivre, Z. Qian, F. Degos, M.-P. Vuillerme, V. Paradis, P. Hammel, P. Ruszniewski, A. Cortes, O. Farges, J. Belghiti, D. Valla, E. Raymond, Cholangiocarcinomes : épidémiologie et prise en charge globale, La Revue de Médecine Interne, 2008, 29, 8, 642

    CrossRef

33. 33
    Ju Hyun Shim, Joong-Won Park, Byung Ho Nam, Woo Jin Lee, Chang-Min Kim, Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2008, 63, 3, 459

    CrossRef

34. 34
    Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi, Koichi Hirata, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano, Fumihiko Miura, Guidelines for chemotherapy of biliary tract and ampullary carcinomas, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 1, 55

    CrossRef

35. 35
    Ryota Masuzaki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Masao Omata, Hepatocellular carcinoma in viral hepatitis: Improving standard therapy, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1137

    CrossRef

36. 36
    Masato Nakamura, Hiroaki Nagano, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Shogo Kobayashi, Hiroshi Wada, Takehiro Noda, Keizo Dono, Koji Umeshita, Morito Monden, Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasis, Cancer, 2008, 112, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(108K)
    • References
37. 37
    Junji Furuse, Postoperative adjuvant treatments for biliary tract cancer, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 5, 463

    CrossRef

38. 38
    Chul Ju Han, Recent developments in systemic chemotherapy for hepatocellular carcinoma, The Korean Journal of Hepatology, 2008, 14, 1, 4

    CrossRef

39. 39
    M. CHAPARRO, L. GONZÁLEZ MORENO, M. TRAPERO-MARUGÁN, J. MEDINA, R. MORENO-OTERO, Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents, Alimentary Pharmacology & Therapeutics, 2008, 28, 11-12

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(130K)
    • References
40. 40
    Junji Furuse, Takuji Okusaka, Narikazu Boku, Shinichi Ohkawa, Akira Sawaki, Toshikazu Masumoto, Akihiro Funakoshi, S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study, Cancer Chemotherapy and Pharmacology, 2008, 62, 5, 849

    CrossRef

41. 41
    L. Costes, M. Ducreux, V. Boige, Traitement systémique du carcinome hépatocellulaire, Oncologie, 2008, 10, 3, 191

    CrossRef

42. 42
    Sharon Weber, William Jarnagin, Austin Duffy, Eileen M. O'Reilly, Ghassan K. Abou-Alfa, Leslie Blumgart, Abeloff's Clinical Oncology, 2008,

    CrossRef

43. 43
    Hideki Nishio, Masato Nagino, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Yuji Nimura, Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications?, Journal of Hepato-Biliary-Pancreatic Surgery, 2007, 14, 4, 351

    CrossRef

44. 44
    Florian Eckel, Roland M Schmid, Emerging drugs for biliary cancer, Expert Opinion on Emerging Drugs, 2007, 12, 4, 571

    CrossRef

45. 45
    V Boige, J-L Raoul, J-P Pignon, O Bouché, J-F Blanc, L Dahan, J-L Jouve, N Dupouy, M Ducreux, Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial, British Journal of Cancer, 2007,

    CrossRef

46. 46
    Weijing Sun, Update in colorectal, hepatobiliary and pancreatic cancers, Update on Cancer Therapeutics, 2007, 2, 3, 141

    CrossRef

47. 47
    Berardi Rossana, Scartozzi Mario, Freddari Federica, Squadroni Michela, Santinelli Alfredo, Bearzi Italo, Fabris Guidalberto, Cascinu Stefano, Biliary tract cancers: Molecular profiling as a tool for treatment decisions. A literature review, Cancer Treatment Reviews, 2006, 32, 5, 333

    CrossRef

48. 48
    Julia Draznin, Weijing Sun, Cancers of the bowel and hepatobiliary tract, Update on Cancer Therapeutics, 2006, 1, 3, 353

    CrossRef

49. 49
    Xabier de Aretxabala, Ivan Roa, Marcela Berrios, Juan Hepp, Jorge Gallardo, Andres Cordova, Juan Carlos Roa, Jorge Leon, Fernando Maluenda, Chemoradiotherapy in gallbladder cancer, Journal of Surgical Oncology, 2006, 93, 8

    Direct Link:

    • Abstract
    • PDF(95K)
    • References
50. 50
    Danish Mazhar, Justin Stebbing, Mark Bower, Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?, Future Oncology, 2006, 2, 4, 509

    CrossRef

51. 51
    Merav A. Ben-David, Kent A. Griffith, Eyad Abu-Isa, Theodore S. Lawrence, James Knol, Mark Zalupski, Edgar Ben-Josef, External-beam radiotherapy for localized extrahepatic cholangiocarcinoma, International Journal of Radiation Oncology*Biology*Physics, 2006, 66, 3, 772

    CrossRef

52. 52
    Richard Quek, Soon Thye Lim, Simon Ong, Hepatocellular carcinoma – Pathological complete response to oral capecitabine, megestrol and thalidomide, Acta Oncologica, 2006, 45, 1, 95

    CrossRef

53. 53
    Shogo Tanaka, Hiromu Tanaka, Takatsugu Yamamoto, Taichi Shuto, Shigekazu Takemura, Seikan Hai, Katsu Sakabe, Takahiro Uenishi, Kazuhiro Hirohashi, Shoji Kubo, Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 3, 228

    CrossRef

54. 54
    J Harder, B Riecken, O Kummer, C Lohrmann, F Otto, H Usadel, M Geissler, O Opitz, H Henß, Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer, British Journal of Cancer, 2006, 95, 7, 848

    CrossRef

55. 55
    Yong Sang Hong, Jeeyun Lee, Sang Cheol Lee, In Gyu Hwang, Seong-Ho Choi, Jin-Seok Heo, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer, Cancer Chemotherapy and Pharmacology, 2006, 60, 3, 321

    CrossRef

56. 56
    Seth J Karp, Yonson Ku, Scott Johnson, Khalid Khwaja, Michael Curry, Douglas Hanto, Surgical and non-surgical approaches to hepatocellular cancer, Current Opinion in Organ Transplantation, 2006, 11, 3, 226

    CrossRef

57. 57
    Jae-Yong Cho, Ji-Sun Nam, Mi-Suk Park, Jeong-Sik Yu, Yong-Han Paik, Se-Joon Lee, Dong-Ki Lee, Dong-Sup Yoon, A Phase II Study of Capecitabine Combined with Gemcitabine in Patients with Advanced Gallbladder Carcinoma, Yonsei Medical Journal, 2005, 46, 4, 526

    CrossRef

58. 58
    Richard C. Cabot, Nancy Lee Harris, Jo-Anne O. Shepard, Sally H. Ebeling, Stacey M. Ellender, Christine C. Peters, Kenneth K. Tanabe, Lawrence S. Blaszkowsky, Raymond T. Chung, Michael A. Blake, Gregory Y. Lauwers, Case 23-2005, New England Journal of Medicine, 2005, 353, 4, 401

    CrossRef

59. 59
    Say-Bee Poh, Li-Yuan Bai, Po-Min Chen, Pegylated Liposomal Doxorubicin-Based Combination Chemotherapy as Salvage Treatment in Patients With Advanced Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2005, 28, 6, 540

    CrossRef

60. 60
    Jian Zhou, Yong-Sheng Xiao, Zhao-You Tang, Jia Fan, Zhi-Quan Wu, Yan Zhao, Qiong Xue, Zao-Zhuo Shen, Yin-Kun Liu, Sheng-Long Ye, Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration, Journal of Cancer Research and Clinical Oncology, 2005, 131, 8, 547

    CrossRef